The FOXM1 SUCC has not been researched, while a previous study indicates that FOXM1 protein can be modified by other post-translational modifications, including phosphorylation, ubiquitination, Ace, and methylation, which may have activator or inhibitory effects on the tumor progression [21]. The gene discussed is FOXM1; the disease is neoplasm.